Delivery Order SPE2DB20D1109-SPE2DB25FP63A
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of GAMUNEX-C 5 gram/50 milliliter vials valued at $3,036.70. This non-competitive delivery order, which must be completed by August 15, 2025, represents a firm fixed-price transaction under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $40,532.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 milliliter vials, with an ultimate completion date of August 22, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of GAMUNEX-C (40 gram/400 mL vial) with a ceiling value of $2,327.20. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 20, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials valued at $11,651.54 under a firm fixed-price contract with an ultimate completion date of August 18, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for GAMUNEX-C 20 gram/200 milliliter vials valued at $11,801.40 with firm fixed pricing. This is a non-set-aside delivery order with an ultimate completion date of September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is executing this...
- The Defense Logistics Agency awarded a $41,178.10 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This competitively awarded, firm fixed-price contract is non-set-aside and scheduled for completion by August 21, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an immune globulin intravenous (human) product used in treating immune deficiency disorders and is a critical pharmaceutical...
- The Defense Logistics Agency awarded a $23,272.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C (40 gram/400 ml vial), with an ultimate completion date of August 13, 2025. This is an unset-aside, competitively awarded contract that will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child order under a larger contract vehicle, this delivery order represents a single transaction within AmerisourceBergen's extensive pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,662.82 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 10 gram/100 milliliter vials. The contract employs firm fixed-price terms with an ultimate completion date of August 22, 2025, and represents a non-competitive set-aside award. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, serving as the company's corporate headquarters and primary distribution hub for federal...
- The Defense Logistics Agency awarded a $23,272 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This firm fixed-price contract, with an ultimate completion date of September 10, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside designation, indicating it was competitively awarded. Performance will be conducted at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 Gram/400 ML Vial (400ML) under a firm fixed-price contract valued at $2,327.20. The delivery order, which carries no set-aside designation, is scheduled for completion by August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract represents a routine pharmaceutical procurement to support military and...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP63ADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,360.28 to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials. This firm fixed price delivery order, awarded on August 22, 2025, with a completion date of September 15, 2025, represents a single pharmaceutical supply transaction under a larger indefinite delivery contract. GAMUNEX-C is an immunoglobulin product used for treating immunodeficiency conditions and represents the type of specialized pharmaceutical commodity that DLA procures to support military and veteran healthcare systems. The award was made through open competition with no set-aside designation, demonstrating AmerisourceBergen's capability to compete for federal medical supply requirements. Performance will be executed from the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a leading pharmaceutical distributor, AmerisourceBergen maintains a significant federal contracting presence supporting critical medical supply needs across multiple therapeutic domains through DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/22/25 |